SUN PHARMA ADVANCED RESEARCH COMPANY
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Sun Pharma Advanced Research Company along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.94₹ -1.3
As on Oct 30, 2025, 4:01 PM IST
Sun Pharma Advanced Research Company Price Performance
Today's LowToday's High
₹136.00₹138.00
₹136.55
52 Weeks' Low52 Weeks' High
₹109.20₹240.95
₹136.55
Open Price
₹138.00
Prev. Close
₹137.85
Volume
24,469
Over the last 5 years, the share price of Sun Pharma Advanced Research Company has declined 3.58% CAGR. Over the past year, the corresponding return has been -36.81%.
Sun Pharma Advanced Research Company’s current P/E of -14.85x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Sun Pharma Advanced Research Company Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sun Pharma Advanced Research Company | 4.08 | 3.25 | -9.03 | -5.92 | -36.77 | -19.11 | -3.58 |
| Suven Life Sciences | -3.78 | -7.47 | -29.75 | 56.48 | 52.62 | 46.67 | 31.27 |
| Vimta Labs | 6.51 | 0.12 | 3.19 | 40.64 | 158.31 | 49.85 | 60.64 |
| Choksi Laboratories | -13.05 | -25.98 | -24.51 | 18.01 | 134.31 | 51.22 | 68.76 |
| Vanta Bioscience | -12.77 | -6.03 | -23.44 | 9.78 | -55.21 | -33.60 | -31.93 |
Over the last one year, Sun Pharma Advanced Research Company has declined 36.77% compared to peers like Suven Life Sciences (52.62%), Vimta Labs (158.31%), Choksi Laboratories (134.31%). From a 5 year perspective, Sun Pharma Advanced Research Company has underperformed peers relative to Suven Life Sciences (31.27%) and Vimta Labs (60.64%).
Sun Pharma Advanced Research Company Financials
Sun Pharma Advanced Research Company Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 134.05 | 136.45 |
| 10 | 132.33 | 134.87 |
| 20 | 131.62 | 134.37 |
| 50 | 138.21 | 137.99 |
| 100 | 147.33 | 144.1 |
| 200 | 149.69 | 157.55 |
Sun Pharma Advanced Research Company Share Holding Pattern
In the latest quarter, Sun Pharma Advanced Research Company saw a drop in promoter holding to 65.69%, while DII stake increased to 1.04%, FII holding rose to 1.76%, and public shareholding moved up to 31.52% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Sun Pharma Advanced Research Company Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 29,56,264 | 0.61 | 38.29 |
* Excluding Index & Arbitrage Funds
Sun Pharma Advanced Research Company Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 29, 2025, 7:20 PM IST | Sun Pharma Advanced - Clarification Regarding Increase In The Volume |
| Oct 29, 2025, 6:19 AM IST | Sun Pharma Advanced - Clarification sought from Sun Pharma Advanced Research Company Ltd |
| Oct 09, 2025, 8:01 PM IST | Sun Pharma Advanced - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Aug 13, 2025, 1:23 AM IST | Sun Pharma Advanced - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 04, 2025, 7:40 PM IST | Sun Pharma Advanced - Unaudited Financial Results For The Quarter Ended June 30, 2025 |
About Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837. Currently Company is involved in the business activities of Research and experimental development on natural sciences and engineering. Company's Total Operating Revenue is Rs. 71.77 Cr. and Equity Capital is Rs. 32.45 Cr. for the Year ended 31/03/2025.
- IndustryMedical Research Services
- AddressPlot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli - Vadodara Highway, Vadodra District Gujarat 391775
- Contact
Management
- Mr. Dilip S ShanghviChairman & Non-Exe.Director
- Dr. T RajamannarNon Executive Director
- Ms. Vidhi ShanghviNon Executive Director
- Mr. Venkateswarlu JastiIndependent Director
- Ms. Bhavna DoshiIndependent Director
- Dr. Ferzaan EngineerIndependent Director
- Dr. Robert J SpiegelIndependent Director
- Mrs. Rekha WarriarIndependent Director
FAQs on Sun Pharma Advanced Research Company Share Price
What is the share price of Sun Pharma Advanced Research Company?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sun Pharma Advanced Research Company is ₹136.55 as on Oct 30, 2025.
What kind of stock is Sun Pharma Advanced Research Company?
The Sun Pharma Advanced Research Company is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Sun Pharma Advanced Research Company?
The market cap of Sun Pharma Advanced Research Company is ₹4,431.34 Cr as on Oct 30, 2025.
What are today's High and Low prices of Sun Pharma Advanced Research Company?
Today’s highest and lowest price of Sun Pharma Advanced Research Company are ₹138.00 and ₹136.00.
What are the 52 Week High and 52 Week Low of Sun Pharma Advanced Research Company?
The 52-week high/low is the highest and lowest price at which Sun Pharma Advanced Research Company stock has traded in the past 52-week or nearly a year. The 52-week high of Sun Pharma Advanced Research Company is ₹240.95 and 52-week low of Sun Pharma Advanced Research Company is ₹109.20 as on Oct 30, 2025.
How has the Sun Pharma Advanced Research Company performed historically in terms of returns?
The Sun Pharma Advanced Research Company has shown returns of -0.94% over the past day, 5.61% for the past month, -10.16% over 3 months, -36.81% over 1 year, -19.11% across 3 years, and -3.58% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Sun Pharma Advanced Research Company?
P/E ratio of and PB ratio of Sun Pharma Advanced Research Company are -14.85 and -57.27 on Oct 30, 2025. While the company gives a dividend yield of 0.00 per annum.
Sun Pharma Advanced Research Company News
✕
Market Pulse